Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
yFFP in Parkinson's Disease
NCT04202757Phase 1Completed
- Sponsor
- The Neurology Center
- Start
- Sep 2018
- Primary completion
- Aug 2019
- Modality
- Recombinant Proteins and Enzymes, Tissue Cells
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Parkinson's disease (PD) comparing Young Fresh Frozen Plasma (yFFP) with Saline Placebo (2 arms). Primary endpoints: Changes in Physician assessment (Modified UPDRS) and Changes in Patient assessment (SPS-6). Started Sep 2018; status: completed.
02
Drugs
young fresh frozen plasma
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04202757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04202757.